From Psychiatric Bind to Clinical Solution: The VMAT2 Revolution in Treating Tardive Dyskinesia
- March 10, 2026
Brain Cancers: FDA Approves Pembrolizumab Combo
Breaking New Ground: Milsaperidone Offers Patients a Fresh Option for Serious Mental Illness
FDA Escalates Scrutiny of GLP‑1 Compounders as Industry Reports Key Clinical and Regulatory Updates
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
🌺 March 10 is National Women and Girls HIV/AIDS Awareness Day.
Today, we honor the strength, resilience, and voices of women and girls affected by HIV, and we recommit to advancing equity, access, and support. This year’s observance highlights the theme Hope, Health, and Healing, focusing on the importance of removing barriers to prevention, testing, and treatment for women and girls.
✨ Today we raise awareness.
Tomorrow, we continue the work.
Every day we stand together.
Join the movement. Share information. Support accessible and stigma free care.
#NWGHAAD #HopeHealthHealing #EndHIV #PatientWorthy
Next Generation Genetic Counselling SADS (Sudden Arrhythmia Death Syndromes) FoundationA negative result is not always the end of the story.
Jessica survived sudden cardiac arrest without a clear diagnosis. Her first genetic test was negative. Five years later, repeat testing identified a PKP2 variant and confirmed Arrhythmogenic Cardiomyopathy. That answer changed her care and guided monitoring for her daughters.
NSGC partnered with the SADS (Sudden Arrhythmia Death Syndromes) Foundation to share why re-evaluation matters in inherited arrhythmias. Read more at the link in comments.
#GeneChat
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.
